Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

420 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Controversies in COX-2 selective inhibition.
Simon LS, Smolen JS, Abramson SB, Appel G, Bombardier C, Brater DC, Breedveld FC, Brune K, Burmester GR, Crofford LJ, Dougados M, DuBois RN, Fitzgerald GA, Frishman W, García Rodríguez LA, Hochberg MC, Kalden JR, Laine L, Langman MJ, Prescott SM, van de Putte LB, Whelton A, White WB, Willaims GH. Simon LS, et al. Among authors: van de putte lb. J Rheumatol. 2002 Jul;29(7):1501-10. J Rheumatol. 2002. PMID: 12136912 Review. No abstract available.
The classification of cyclooxygenase inhibitors.
Lipsky LP, Abramson SB, Crofford L, Dubois RN, Simon LS, van de Putte LB. Lipsky LP, et al. Among authors: van de putte lb. J Rheumatol. 1998 Dec;25(12):2298-303. J Rheumatol. 1998. PMID: 9858421 Review.
Cyclooxygenase in biology and disease.
Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. Dubois RN, et al. Among authors: van de putte lb. FASEB J. 1998 Sep;12(12):1063-73. FASEB J. 1998. PMID: 9737710 Free article. Review.
[Immunotherapy in rheumatoid arthritis; current status].
Breedveld FC, van de Putte LB. Breedveld FC, et al. Among authors: van de putte lb. Ned Tijdschr Geneeskd. 1996 Jun 15;140(24):1255-9. Ned Tijdschr Geneeskd. 1996. PMID: 8700279 Review. Dutch. No abstract available.
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003).
Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Dougados M, Emery P, Gibofsky A, Kavanaugh AF, Keystone EC, Klareskog L, Russell AS, van de Putte LB, Weisman MH. Furst DE, et al. Among authors: van de putte lb. Ann Rheum Dis. 2003 Nov;62 Suppl 2(Suppl 2):ii2-9. doi: 10.1136/ard.62.suppl_2.ii2. Ann Rheum Dis. 2003. PMID: 14532138 Free PMC article. Review. No abstract available.
Basic biology and clinical application of specific cyclooxygenase-2 inhibitors.
Crofford LJ, Lipsky PE, Brooks P, Abramson SB, Simon LS, van de Putte LB. Crofford LJ, et al. Among authors: van de putte lb. Arthritis Rheum. 2000 Jan;43(1):4-13. doi: 10.1002/1529-0131(200001)43:1<4::AID-ANR2>3.0.CO;2-V. Arthritis Rheum. 2000. PMID: 10643694 Free article. Review.
Access to disease modifying treatments for rheumatoid arthritis patients.
Furst DE, Breedveld FC, Burmester GR, Crofford L, Emery P, Feldman M, Kalden JR, Kavanaugh A, Keystone E, Lipsky PE, Maini RN, Moreland L, Smolen JS, Van De Putte L, Vischer T, Weinblatt M, Weissman M. Furst DE, et al. Ann Rheum Dis. 1999 Nov;58 Suppl 1(Suppl 1):I129-30. doi: 10.1136/ard.58.2008.i129. Ann Rheum Dis. 1999. PMID: 10577989 Free PMC article. Review. No abstract available.
420 results